Status:
COMPLETED
Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial
Lead Sponsor:
Gynuity Health Projects
Conditions:
Abortion, Induced
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The primary goal of this study is to determine the clinical advantage of pre-treatment with mifepristone in second trimester misoprostol induction abortion. This will be a randomized controlled double...
Eligibility Criteria
Inclusion
- 14 to 21 weeks gestation, based on menstrual history and clinical exam (with or without ultrasound)
- Meet legal criteria to obtain abortion
- Present with closed cervical os and no vaginal bleeding
- Live fetus at time of presentation for service
- Have no contraindications to study procedures, according to provider
- Be able to consent to procedure, either by reading consent document or by having consent document read to her
- Be willing to follow study procedures
Exclusion
- Known previous transmural uterine incision
- Known allergy to mifepristone or misoprostol/prostaglandin or other contraindications to the use of mifepristone or misoprostol
- Any contraindications to vaginal delivery, including placenta previa
- Presentation in active labor (defined as moderate to severe contractions every 10 minutes or less)
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00784186
Start Date
August 1 2008
End Date
August 1 2009
Last Update
February 20 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
National Ob-Gyn Hospital
Hanoi, Vietnam
2
Hung Vuong Hospital
Ho Chi Minh City, Vietnam